Post operative pain
Conditions
Interventions
Trade Name: Chirocaine
Product Name: Chirocaine
Pharmaceutical Form: Injection*
INN or Proposed INN: LEVOBUPIVACAINE
CAS Number: 2726247
Sponsors
Hull and east Yorkshire Hospital NHS Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria will be all women about to undergo minor laparoscopic surgery. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Exclusions will be women with a BMI>35 or with an ASA >2, known previous adverse reaction or any contraindication to levobupivacaine. It is also necessary to exclude women who have a painful condition immediately prior to the surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: The principle research question is whether leaving a local anaesthetic solution in the abdomen after keyhole surgery improves pain relief.;Secondary Objective: Secondary research questions are whether leaving a local anaesthetic solution in the abdomen after keyhole surgery reduces the need for other pain killing agents and reduces the duration of hospital stay.;Primary end point(s): The pain score in the evening after surgery.(8hours) | — |
Countries
United Kingdom
Outcome results
None listed